




The global Pet Parasiticide market is projected to reach a size of $2.7 billion by 2025, driven by increasing pet ownership and awareness of parasite prevention. Growth is fueled by demand for topical and oral formulations, with North America and Europe leading in market share. Emerging economies show promising opportunities for market expansion.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Boehringer Ingelheim
◍ Merck
◍ Virbac
◍ Vetoquinol
◍ Ceva Sante Animale
◍ HealthforAnimals
◍ BSAVA Sheldon Middleton
◍ Bayer
◍ Elanco
◍ Zoetis
◍ Chanelle
◍ Bimeda Animal Health
The Pet Parasiticide Market is highly competitive with key players such as Boehringer Ingelheim, Merck, Virbac, Vetoquinol, Ceva Sante Animale, BSAVA Sheldon Middleton, Bayer, Elanco, Zoetis, Chanelle, Bimeda Animal Health. These companies offer a range of products to prevent and treat parasitic infections in pets, contributing to the growth of the market.
- Boehringer Ingelheim: Sales revenue of $18.9 billion.
- Merck: Sales revenue of $46.84 billion.
- Virbac: Sales revenue of $961.3 million.
Request Sample Report
By Application
◍ Online Sales
◍ Offline Sales
By Product
◍ Internal Parasites
◍ External Parasites
Request Sample Report
Request Sample Report
$ X Billion USD